Logo image of CURO

CURO GROUP HOLDINGS CORP (CURO) Stock Fundamental Analysis

NYSE:CURO - New York Stock Exchange, Inc. - US23131L1070 - Common Stock - Currency: USD

0.1929  -0.01 (-6.4%)

Fundamental Rating

2

Taking everything into account, CURO scores 2 out of 10 in our fundamental rating. CURO was compared to 52 industry peers in the Consumer Finance industry. CURO may be in some trouble as it scores bad on both profitability and health. CURO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year CURO has reported negative net income.
In the past year CURO had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: CURO reported negative net income in multiple years.
Of the past 5 years CURO 4 years had a positive operating cash flow.
CURO Yearly Net Income VS EBIT VS OCF VS FCFCURO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M 600M

1.2 Ratios

CURO has a Return On Assets of -23.05%. This is amonst the worse of the industry: CURO underperforms 86.54% of its industry peers.
CURO has a better Return On Invested Capital (3.42%) than 61.54% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CURO is below the industry average of 8.74%.
Industry RankSector Rank
ROA -23.05%
ROE N/A
ROIC 3.42%
ROA(3y)-6.4%
ROA(5y)-0.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.51%
ROIC(5y)9.07%
CURO Yearly ROA, ROE, ROICCURO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 400 600

1.3 Margins

CURO's Operating Margin of 8.81% is in line compared to the rest of the industry. CURO outperforms 48.08% of its industry peers.
CURO's Operating Margin has declined in the last couple of years.
The Profit Margin and Gross Margin are not available for CURO so they could not be analyzed.
Industry RankSector Rank
OM 8.81%
PM (TTM) N/A
GM N/A
OM growth 3Y-14.47%
OM growth 5Y-9.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CURO Yearly Profit, Operating, Gross MarginsCURO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CURO is destroying value.
Compared to 1 year ago, CURO has more shares outstanding
CURO has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CURO has a worse debt to assets ratio.
CURO Yearly Shares OutstandingCURO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M 40M
CURO Yearly Total Debt VS Total AssetsCURO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that CURO is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.37, CURO is in line with its industry, outperforming 42.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACC0.65
WACC5.29%
CURO Yearly LT Debt VS Equity VS FCFCURO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1B 2B

2.3 Liquidity

A Current Ratio of 1.44 indicates that CURO should not have too much problems paying its short term obligations.
CURO has a Current ratio of 1.44. This is comparable to the rest of the industry: CURO outperforms 55.77% of its industry peers.
CURO has a Quick Ratio of 1.44. This is a normal value and indicates that CURO is financially healthy and should not expect problems in meeting its short term obligations.
CURO's Quick ratio of 1.44 is in line compared to the rest of the industry. CURO outperforms 55.77% of its industry peers.
Industry RankSector Rank
Current Ratio 1.44
Quick Ratio 1.44
CURO Yearly Current Assets VS Current LiabilitesCURO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

CURO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -483.10%.
The Revenue for CURO has decreased by -20.04% in the past year. This is quite bad
CURO shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.44% yearly.
EPS 1Y (TTM)-483.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.31%
Revenue 1Y (TTM)-20.04%
Revenue growth 3Y-7.42%
Revenue growth 5Y-8.44%
Sales Q2Q%-9.92%

3.2 Future

The Earnings Per Share is expected to grow by 29.82% on average over the next years. This is a very strong growth
CURO is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.43% yearly.
EPS Next Y64.51%
EPS Next 2Y37.76%
EPS Next 3Y29.82%
EPS Next 5YN/A
Revenue Next Year-2.88%
Revenue Next 2Y2.88%
Revenue Next 3Y4.43%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CURO Yearly Revenue VS EstimatesCURO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M 1B
CURO Yearly EPS VS EstimatesCURO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 2 -2 -4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CURO. In the last year negative earnings were reported.
Also next year CURO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CURO Price Earnings VS Forward Price EarningsCURO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as CURO.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.49
CURO Per share dataCURO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10

4.3 Compensation for Growth

A more expensive valuation may be justified as CURO's earnings are expected to grow with 29.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y37.76%
EPS Next 3Y29.82%

More info and screens

0

5. Dividend

5.1 Amount

CURO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CURO GROUP HOLDINGS CORP

NYSE:CURO (3/11/2024, 8:13:51 PM)

0.1929

-0.01 (-6.4%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryConsumer Finance
Earnings (Last)02-05 2024-02-05/bmo
Earnings (Next)05-08 2024-05-08/amc
Inst Owners1.24%
Inst Owner Change-8.28%
Ins Owners12.63%
Ins Owner Change0%
Market Cap7.97M
Analysts45.71
Price Target0.71 (268.07%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.34
Dividend Growth(5Y)N/A
DP-0.12%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-47.45%
Min EPS beat(2)-90.63%
Max EPS beat(2)-4.26%
EPS beat(4)0
Avg EPS beat(4)-172.63%
Min EPS beat(4)-528.71%
Max EPS beat(4)-4.26%
EPS beat(8)3
Avg EPS beat(8)-267.12%
EPS beat(12)7
Avg EPS beat(12)-146.97%
EPS beat(16)10
Avg EPS beat(16)-100.78%
Revenue beat(2)0
Avg Revenue beat(2)-8.86%
Min Revenue beat(2)-15.56%
Max Revenue beat(2)-2.15%
Revenue beat(4)0
Avg Revenue beat(4)-6.1%
Min Revenue beat(4)-15.56%
Max Revenue beat(4)-1.79%
Revenue beat(8)2
Avg Revenue beat(8)-3.22%
Revenue beat(12)3
Avg Revenue beat(12)2.65%
Revenue beat(16)3
Avg Revenue beat(16)0.2%
PT rev (1m)-70%
PT rev (3m)-70%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.17%
EPS NY rev (1m)-1.54%
EPS NY rev (3m)-0.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-0.09%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF 0.94
P/B N/A
P/tB N/A
EV/EBITDA 20.49
EPS(TTM)-4.14
EYN/A
EPS(NY)-1.56
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)0.21
OCFY106.69%
SpS19.46
BVpS-9.64
TBVpS-18.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -23.05%
ROE N/A
ROCE 4.33%
ROIC 3.42%
ROICexc 3.6%
ROICexgc 4.68%
OM 8.81%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-6.4%
ROA(5y)-0.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)4.51%
ROIC(5y)9.07%
ROICexc(3y)4.68%
ROICexc(5y)10.21%
ROICexgc(3y)6.21%
ROICexgc(5y)13.46%
ROCE(3y)5.71%
ROCE(5y)11.49%
ROICexcg growth 3Y-37.62%
ROICexcg growth 5Y-28.14%
ROICexc growth 3Y-37.14%
ROICexc growth 5Y-28.39%
OM growth 3Y-14.47%
OM growth 5Y-9.91%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 21.27
Cap/Depr 80.74%
Cap/Sales 2.45%
Interest Coverage 250
Cash Conversion 8.93%
Profit Quality N/A
Current Ratio 1.44
Quick Ratio 1.44
Altman-Z 0.37
F-Score4
WACC5.29%
ROIC/WACC0.65
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-483.1%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-179.31%
EPS Next Y64.51%
EPS Next 2Y37.76%
EPS Next 3Y29.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-20.04%
Revenue growth 3Y-7.42%
Revenue growth 5Y-8.44%
Sales Q2Q%-9.92%
Revenue Next Year-2.88%
Revenue Next 2Y2.88%
Revenue Next 3Y4.43%
Revenue Next 5YN/A
EBIT growth 1Y16.64%
EBIT growth 3Y-20.81%
EBIT growth 5Y-17.51%
EBIT Next Year-13.66%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-103.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-97.87%
OCF growth 3YN/A
OCF growth 5YN/A